AnaptysBio to abandon eczema drug development

AnaptysBio Stock Under Pressure After Scrapping Eczema Drug Program: Retail Is Devastated
Shares of AnaptysBio Inc. remained flat in premarket trading Thursday after plunging over 32% in the prior session, marking the stock’s steepest single-day loss since March 2021. The collapse followed the company’s announcement that it would halt further investment in its experimental therapy ANB032 after the drug failed to meet primary and
AnaptysBio to abandon eczema drug development after mid-stage trial failure
AnaptysBio will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a mid-stage trial, the company said on Wednesday, dragging its shares nearly 40% lower.
AnaptysBio Stock Down as Eczema Study Fails to Meet Goals
Shares of AnaptysBio, Inc. ANAB, a clinical-stage biotechnology company, plunged 32.8% on Dec. 11 after it announced that the phase IIb study of pipeline candidate, ANB032, a BTLA agonist, was unsuccessful.
AnaptysBio to Drop Eczema Drug Candidate After Trials Miss Endpoints; Shares Fall
AnaptysBio shares plummeted in premarket trading Wednesday after the company said it will discontinue its dermatitis treatment after the drug failed to meet its targets in recent trials. Shares fell over 39% to $14 ahead of the morning bell.
AnaptysBio Discontinues Investment In Eczema Candidate After Disappointing Data
AnaptysBio, Inc. (NASDAQ:ANAB) announced that investigational ANB032, a BTLA agonist, did not meet the primary and secondary endpoints in any of the doses studied in the ARISE-AD trial as a monotherapy for moderate-to-severe atopic dermatitis (AD) or eczema.

Nara Smith, Eczema

Nara Smith Details Gruesome Eczema Flare-Up That Left Her Body 'Oozing' and 'Swollen' — and How She Found Relief in Lupus Diagnosis
Nara Smith shared images and a lengthy caption detailing the health challenges she's experienced in the three years since her ...
An All-Weather Guide To Eczema And Your Skin
Discover how different types of weather, from scorching heat to chilly winds, can wreak havoc on your skin and learn ...
FierceBiotech1d
Q32's stock plunges in wake of phase 2 eczema fail for anti-IL-7R antibody
Q32 Bio still sees potential for its anti-IL-7R antibody as an alopecia treatment despite failing a phase 2 eczema study—but ...
I Have Eczema, and These Are the Products That Don't Bother My Skin
These ten essentials keep my skin hydrated, soothed, and protected from inflammation, itchiness, and occasional scaliness.
The best moisturisers for eczema, according to experts
Eczema-prone skin needn't mean a mundane moisturiser; our edit includes the ingredient-led, the fragranced and the luxurious ...
Onlymyhealth1d
Try THIS If You Have Eczema Or Psoriasis
Managing eczema or psoriasis requires a wide approach Hence by focusing on sugar control a high-protein diet and incorporating diluted apple cider vinegar you can take meaningful steps toward healthie ...
Investors Slaughter Q32 Bio On A 'Messy' Update In Eczema, Alopecia Treatment
Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record ...